0370 1500 100
Request a call back
Send us an email
Request a call back
Send us an email
I am a Consultant in the Personal Injury department, with particular experience of group litigation on behalf of claimants including cases involving child abuse, defective products and medical negligence.
I have been involved in some of the most important and high profile group action cases, including:
I was also involved in claims arising from the ‘Marchioness’ disaster, including the judicial review proceedings resulting in the resumption of the inquest and representation of victims and families at the Marchioness public enquiry and non-statutory enquiry.
“We are well aware of the devastating effects synthetic mesh implants can have on patients, causing debilitating pain and reducing quality of life significantly.
“The proposal by Sandwell and West Birmingham Hospitals NHS Trust to establish a scheme for the resolution of these claims is welcomed on behalf of our clients. Such a process will hopefully mean that claims are resolved more quickly, more efficiently and more cost effectively.
“We have worked with the NHS to set up schemes in similar situations where there have been a lot of people affected in a similar way and it is the least confrontational way of securing patients the help and support they need to be able to move on with their lives.
“It is important for ladies who feel they may have been affected to contact the Trust and seek further medical advice. Patients can also seek legal advice if they remain dissatisfied with the treatment they have received.”
It is absolutely vital that ICL and other authorities work swiftly together to determine what caused the fire and, more importantly, how it could have been prevented.
The workers involved in this incident and their families will no doubt be looking for answers and reassurances about safety and it is crucial they get them.
It is imperative that, if there are any lessons to be learned from the investigation, they are welcomed and that new measures will be put in place to ensure risk of future incidents is minimised.
“We have seen a number of ladies affected by TVM products, the results of which can be devastating and reduce quality of life significantly. It is very worrying to see that a surgeon may have continued to implant such risky devices against both the Trust’s and NICE guidelines. Some women may well have received these devices when there were other, safer, treatment options available to them.
“It is reassuring to see that the Trust has voluntarily recalled its patients to provide them with the advice and support. However, it is worrying that it is alleged Mr Arun has been acting against the advice of the Trust since 2009. We have been instructed to investigate on behalf of a patient who has been affected who is concerned about her treatment.
“The implications of such medical errors can have a devastating effect on patients. It is essential that those patients who have concerns over their treatment, particularly in relation to Mr Arun, seek an urgent explanation and reassurance.
“It is important for those ladies who feel they may have been affected to contact the Trust to seek further medical advice. It should be incumbent upon the Trust to contact all patients affected by Mr Arun’s practices, and to provide them with all the necessary information regarding the ongoing investigation. Patients can seek legal advice if they remain dissatisfied with the treatment they have received.”
“Trans-Vaginal Meshes are very high risk products and should in effect only be used as a last resort treatment option.
“The reclassification of TVM products should bring more awareness to patients of the fact that these are such high risk products. It should also help to ensure that women are properly informed of the risks associated with these products and for their treating consultants to advise of all alternative procedures available to them.
“A reclassification of this medical device will hopefully also lead to more accurate data about the safety of these products in the long term which has been woefully inadequate to date. It will also bring about a more effective and controlled way of introducing these products to the medical market with more scrutiny before they are available to use.
“Steps such as this taken by the FDA are important in identifying and improving safety standards, in the hope that devices like this no longer expose patients to the risk of serious injury.”